<bill session="116" type="h" number="5632" updated="2020-07-13T18:41:17Z">
  <state datetime="2020-01-16">REFERRED</state>
  <status>
    <introduced datetime="2020-01-16"/>
  </status>
  <introduced datetime="2020-01-16"/>
  <titles>
    <title type="short" as="introduced">FDA Accountability for Public Safety Act</title>
    <title type="short" as="introduced">FDA Accountability for Public Safety Act</title>
    <title type="display">FDA Accountability for Public Safety Act</title>
    <title type="official" as="introduced">To establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.</title>
  </titles>
  <sponsor bioguide_id="K000394"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-01-16">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-01-16" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="identical" number="418"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Federal officials"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government ethics and transparency, public corruption"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
